Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.76NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.301NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.269NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.234NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Z.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
V.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.282NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.131NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.274NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.235NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.65NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.45NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.165NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBSNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.2.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAHNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBJ.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EP.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CL.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.8.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAUNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.25.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XADNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XABNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FT.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XALNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBWNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GY.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.38NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CT.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.10.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FF.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.99NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.343NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used